Skip to main content
TipRanks
Go Ultimate75% OFF

Trupanion (TRUP) AI Stock Analysis

606 Followers
TRUP

Trupanion

(NASDAQ:TRUP)

Select Model
Rating:71Outperform
Price Target:$38.00▲(5.94% Upside)
Action:reiterated
Date:11/06/26

The score is driven primarily by improving financial performance and cash flow alongside a very positive earnings outlook (record profitability/cash flow and raised guidance). Technicals support the trend but are overextended (very high RSI/Stoch), and the high P/E with no dividend yield meaningfully tempers the overall rating.

Positive Factors
Recurring growth and retentionRecurring premium growth, rising enrolled pets, and seven straight quarters of retention improvement support a durable revenue base. Better retention can lift customer lifetime economics and reduce the acquisition burden as the insured population expands.
Negative Factors
Veterinary cost inflationPersistent double-digit veterinary inflation can raise claim costs faster than pricing or retention can absorb, pressuring the value proposition and underwriting margin. Management expects the issue through 2027, making it a continuing earnings sensitivity rather than a brief event.

Trupanion Key Performance Indicators (KPIs)

Gross Profit by SegmentShows profitability across different business areas, highlighting which segments drive earnings and where there may be opportunities or challenges.

$0.00$20.00M$40.00M$60.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Subscription gross profit is the clear earnings engine: improving per‑pet economics, a better loss ratio and automation have driven sustained margin expansion and created the AOI that management is redeploying into disciplined pet acquisition and product rollout. The “Other” line is small and volatile—recent partner enrollment headwinds have capped its contribution—so Trupanion’s upside depends on sustaining subscription pricing/retention and controlling rising acquisition costs and reserve variability, which are the main near‑term risks to continued gross profit momentum.

Data provided by:The Fly

Trupanion (TRUP) vs. SPDR S&P 500 ETF (SPY)

-40%-30%-20%-10%0%10%20%TRUP+1.33%SPY+9.80%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.59B
Dividend Yield
―
Average Volume (3M)
435.76K
Price to Earnings (P/E)
60.1
Beta (1Y)
0.99
Revenue Growth
11.41%
EPS Growth
70.52%
Country
US
Employees
1,121
Sector
Financial
Sector Strength
68
Industry
Insurance - Property & Casualty

Trupanion Business Overview & Revenue Model

Company Description

Trupanion, Inc. provides monthly subscription-based medical insurance for canine and feline companions across the United States, Canada, Puerto Rico, and Australia. The company's operations are divided into two main categories: Subscription Business...

How the Company Makes Money

Trupanion makes money primarily by selling and administering pet medical insurance policies and collecting recurring premium revenue from enrolled pet owners. The core revenue stream is subscription-like insurance premiums (typically paid monthly) fo...

Trupanion Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:3.31%|Next Earnings Date:Feb 17, 2027
Earnings Call SentimentPositive

The call was strongly positive, with record adjusted operating income and free cash flow, continued growth in pets and retention, improved acquisition efficiency, expanding technology and AI capabilities, and an increased full-year outlook. The company also acknowledged lower subscription value proposition, elevated double-digit cost inflation, higher fixed expenses, the planned Pets Best runoff, and limited near-term Landspath revenue, but these challenges were outweighed by the reported operating momentum and financial performance.

Positive Updates

Record Adjusted Operating Income
Third-quarter adjusted operating income exceeded $47 million, an all-time high and a 15% increase from the prior-year period. Subscription adjusted operating income reached an all-time high of $45.4 million, up 16% year over year, with a 15.8% adjusted operating margin versus 15.5%.

Negative Updates

Lower Subscription Value Proposition
The subscription business cost of paying veterinary invoices was $200.6 million, resulting in a value proposition of 69.7% versus 70.1% in the prior-year period. The quarter also included $600 thousand of adverse prior-period development, or approximately 20 basis points of subscription revenue.

Company Guidance

For the full year of 2026, Trupanion expects total revenue in the range of $1.59 billion to $1.597 billion, subscription revenue between $1.131 billion and $1.133 billion, and total adjusted operating income between $179 million and $182 million, or 19% year over year growth at the midpoint; for the fourth quarter of 2026, total revenue is expected in the range of $407 million to $414 million, subscription revenue between $297 million and $299 million, representing approximately 14% year over year growth at the midpoint, and total adjusted operating income in the range of $48 million to $51 million, representing approximately 10% growth year over year at the midpoint, with projections using a 72% conversion rate; management expects continuous double-digit inflation in 2027, said pricing assumes that, and anticipates average member increase to continue to ease off in 2027.

Trupanion Financial Statement Overview

Summary

Financials show a clear turnaround with improving profitability (positive net income/ROE after prior losses) and strong recent cash generation (solid TTM operating cash flow and free cash flow with good earnings-to-cash support). Offsetting this, profitability remains thin and gross margin has been volatile, implying sensitivity to underwriting/claims dynamics and cost control.

Income Statement

72Positive

Balance Sheet

74Positive

Cash Flow

80Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.56B1.44B1.29B1.11B905.18M698.99M
Gross Profit351.28M410.33M178.80M131.02M122.19M104.35M
EBITDA54.70M51.59M21.33M-20.48M-29.01M-23.25M
Net Income26.62M19.43M-9.63M-44.69M-44.67M-35.53M
Balance Sheet
Total Assets921.62M915.04M806.85M782.95M671.63M562.58M
Cash, Cash Equivalents and Short-Term Investments396.84M370.73M307.38M277.17M222.41M213.41M
Total Debt104.47M111.78M128.89M128.93M69.46M0
Total Liabilities522.42M531.11M483.58M479.23M366.33M230.38M
Stockholders Equity399.20M383.94M323.27M303.72M305.30M332.20M
Cash Flow
Free Cash Flow86.71M75.36M38.57M358.00K-25.09M-4.90M
Operating Cash Flow95.55M89.49M48.29M18.64M-8.00M7.46M
Investing Cash Flow-45.92M-95.89M-13.46M7.64M-67.52M-51.91M
Financing Cash Flow-38.44M-22.86M-3.96M59.13M60.74M-1.13M

Trupanion Technical Analysis

Technical Analysis SentimentPositive
Last Price35.87

Price Trends

50DMA28.34Positive
100DMA27.87Positive
200DMA26.75Positive

Market Momentum

MACD2.28Negative
RSI74.57Negative
STOCH67.23Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRUP, the sentiment is Positive. The current price of 35.87 is above the 20-day moving average (MA) of 32.87, above the 50-day MA of 28.34, and above the 200-day MA of 26.75, indicating a bullish trend. The MACD of 2.28 indicates Negative momentum. The RSI at 74.57 is Negative, neither overbought nor oversold. The STOCH value of 67.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TRUP.

Trupanion Risk Analysis

Trupanion disclosed 112 risk factors in its most recent earnings report. Trupanion reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Concentrated ownership of our common stock could limit your ability to influence the outcome of matters subject to stockholder approval. This concentration may also create a risk of sudden changes in our common stock price.Q4, 2025
2.Our substantial indebtedness could adversely affect our financial condition and prevent us from fulfilling our obligations.Q4, 2025
3.If the transition of our underwriting activity in Canada to our underwriting subsidiary GPIC from Accelerant, a third-party underwriter, is delayed or unsuccessful, our business, operating results and financial condition may be harmed.Q4, 2025

Trupanion Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

TRUP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AFGAFG84Outperform$13.07B12.8721.42%4.40%2.13%28.64%
CBCB84Outperform$141.76B12.8915.06%1.07%5.89%19.00%
PGRPGR83Outperform$132.37B11.4835.44%6.08%7.65%8.90%
ERIEERIE82Outperform$12.71B22.3323.86%2.12%1.97%-11.09%
TRUPTRUP71Outperform$1.59B60.136.71%―11.41%70.52%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
LMNDLMND54Neutral$3.07B-20.49-28.59%―89.43%20.78%

* Financial Sector Average

Performance Comparison

-40%-20%0%20%40%TRUPCBAFGERIEPGRLMNDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TRUP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TRUPTrupanion Inc.35.87-0.03-0.08%
CBChubb Ltd370.1175.4525.61%
AFGAmerican Financial156.8726.6520.47%
ERIEErie Indemnity268.94-20.59-7.11%
PGRThe Progressive Corporation229.9616.917.94%
LMNDLemonade Inc38.22-29.13-43.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026